LICENSE AGREEMENTS (Details Textual)	1 Months Ended		9 Months Ended								9 Months Ended
	Dec. 27, 2013 USD ($)	Feb. 29, 2012 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2014 EUR (€)	Sep. 30, 2014 Minimum [Member] USD ($)	Sep. 30, 2014 Maximum [Member] USD ($)	Sep. 30, 2014 Maximum [Member] JHU License Agreement [Member] USD ($)	Sep. 30, 2014 Completion of Phase One [Member] USD ($)	Sep. 30, 2014 Completion of Phase One [Member] Minimum [Member] USD ($)	Sep. 30, 2014 Obtention of FDA Approval [Member] Maximum [Member] USD ($)	Sep. 30, 2014 Mayo License Agreement [Member]	Sep. 30, 2014 First and Second Anniversary [Member] USD ($)	Sep. 30, 2014 Tenth Anniversary and Thereafter [Member] USD ($)
LICENSE AGREEMENTS [Line Items]
Proceeds From Development Fee	$ 12,500,000		$ 12,500,000
Additional Milestone Payments to be Received Contingent upon Exercise of Options	325,000,000
Common Stock Issued as Additional Consideration for Grant of Certain Rights											18,000
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases								100,000		1,000,000
Accrued Milestone Payments							1,850,000		100,000
Payments for Royalties				20,000								5,000	20,000
Development Milestones					350,000	800,000
Reimbursement Revenue		$ 195,500	$ 1,550,000